Željko Reiner

10.2k total citations · 1 hit paper
28 papers, 990 citations indexed

About

Željko Reiner is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Željko Reiner has authored 28 papers receiving a total of 990 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Željko Reiner's work include Lipoproteins and Cardiovascular Health (15 papers), Cancer, Lipids, and Metabolism (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). Željko Reiner is often cited by papers focused on Lipoproteins and Cardiovascular Health (15 papers), Cancer, Lipids, and Metabolism (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). Željko Reiner collaborates with scholars based in Croatia, Iran and Poland. Željko Reiner's co-authors include Guy De Backer, Ian Graham, Alberico L. Catapano, Paul N. Durrington, Serap Erdine, Gabriele Riccardi, John Kjekshus, Robert F. Storey, Julian Halcox and Richard Hobbs and has published in prestigious journals such as Circulation, Clinica Chimica Acta and Atherosclerosis.

In The Last Decade

Željko Reiner

23 papers receiving 958 citations

Hit Papers

ESC/EAS Guidelines for the management of dyslipidaemias 2011 2026 2016 2021 2011 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Željko Reiner Croatia 11 655 347 265 192 129 28 990
David Colquhoun Australia 11 631 1.0× 341 1.0× 341 1.3× 129 0.7× 143 1.1× 16 1.1k
James Underberg United States 19 587 0.9× 264 0.8× 287 1.1× 189 1.0× 114 0.9× 55 966
Martin P. Bogsrud Norway 20 739 1.1× 241 0.7× 274 1.0× 139 0.7× 229 1.8× 84 1.1k
Aditi Sapre United States 13 882 1.3× 420 1.2× 178 0.7× 191 1.0× 274 2.1× 23 1.2k
Peter H. Jones United States 9 780 1.2× 349 1.0× 302 1.1× 220 1.1× 174 1.3× 13 1.1k
Binh An P. Phan United States 14 469 0.7× 165 0.5× 307 1.2× 98 0.5× 124 1.0× 24 938
Sondra M. DePalma United States 6 733 1.1× 267 0.8× 282 1.1× 359 1.9× 107 0.8× 13 986
Benjamin Neely United States 9 512 0.8× 198 0.6× 373 1.4× 257 1.3× 57 0.4× 20 1.0k
Antonio J. Vallejo‐Vaz Spain 19 877 1.3× 469 1.4× 369 1.4× 172 0.9× 282 2.2× 51 1.5k
José Luis Zamorano Spain 5 994 1.5× 472 1.4× 468 1.8× 367 1.9× 187 1.4× 9 1.5k

Countries citing papers authored by Željko Reiner

Since Specialization
Citations

This map shows the geographic impact of Željko Reiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Željko Reiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Željko Reiner more than expected).

Fields of papers citing papers by Željko Reiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Željko Reiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Željko Reiner. The network helps show where Željko Reiner may publish in the future.

Co-authorship network of co-authors of Željko Reiner

This figure shows the co-authorship network connecting the top 25 collaborators of Željko Reiner. A scholar is included among the top collaborators of Željko Reiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Željko Reiner. Željko Reiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Titlić, Marina, et al.. (2025). Reshaping Dyslipidaemia Treatment with Bempedoic Acid—A Narrative Review. Biomedicines. 13(6). 1460–1460.
2.
Mirhadi, Elaheh, et al.. (2025). The effect of laparoscopic sleeve gastrectomy on serum uric acid levels: a meta-analysis. European surgery. Supplement/European surgery. 58(1). 36–47.
3.
Leiviskä, Jaana, Jouko Sundvall, Kornelia Kotseva, et al.. (2025). Residual cardiovascular risk is tracked by apolipoprotein B in coronary patients with elevated serum triglyceride levels: the ESC EORP EUROASPIRE IV survey. Clinica Chimica Acta. 579. 120653–120653. 1 indexed citations
4.
Mirhadi, Elaheh, et al.. (2025). Effects of Pioglitazone On Lipoprotein(a): A Meta-analysis. Current Atherosclerosis Reports. 27(1). 94–94.
5.
Razi, Bahman, Danyal Imani, Saeed Aslani, Željko Reiner, & Amirhossein Sahebkar. (2024). Statin Therapy and C-reactive Protein in Patients with Kidney Disease: A Systematic Review and Meta-analysis of Randomized Clinical Trials. Current Drug Targets. 26(2). 132–145. 2 indexed citations
6.
Razi, Bahman, Bahman Razi, Saeed Aslani, et al.. (2024). Effect of Statins on Serum Levels of TNF-alpha and Interleukin-6 in Patients withKidney Disease: A Meta-analysis of Randomized Clinical Trials. Current Pharmaceutical Design. 30(20). 1564–1577. 2 indexed citations
7.
Hrabač, Pero, et al.. (2024). PCSK9 inhibition: from effectiveness to cost-effectiveness. Frontiers in Cardiovascular Medicine. 11. 1339487–1339487. 12 indexed citations
8.
Jamialahmadi, Tannaz, Željko Reiner, Luis E. Simental‐Mendía, et al.. (2024). Effect of statins on arterial wall inflammation as assessed by 18F-FDG PET CT: an updated systematic review and meta-analysis. Journal of Inflammation. 21(1). 52–52.
9.
Jamialahmadi, Tannaz, Željko Reiner, Maryam Matbou Riahi, et al.. (2023). Statins and Portal Hypertension: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Current Medicinal Chemistry. 32(7). 1323–1332. 1 indexed citations
10.
Yaribeygi, Habib, et al.. (2023). Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Increases Antioxidative Capacity and Improves Renal Function in Diabetic Rats. Journal of Clinical Medicine. 12(11). 3815–3815. 16 indexed citations
11.
Banach, Maciej, Stanisław Surma, Željko Reiner, et al.. (2022). Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022). Cardiovascular Diabetology. 21(1). 263–263. 56 indexed citations
12.
Abbasifard, Mitra, et al.. (2022). Statin Use in COVID-19 Hospitalized Patients and Outcomes: A Retrospective Study. Frontiers in Cardiovascular Medicine. 9. 820260–820260. 31 indexed citations
13.
Pećin, Ivan, et al.. (2021). Prophylactic therapeutic plasma exchange in pregnant woman with Familial Chylomicronemia Syndrome – A case report. Transfusion and Apheresis Science. 61(3). 103346–103346. 2 indexed citations
14.
Jukema, J. Wouter, Laurien E. Zijlstra, Deepak L. Bhatt, et al.. (2019). Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES. Circulation. 140(25). 2054–2062. 85 indexed citations
15.
Sahebkar, Amirhossein, Željko Reiner, Luis E. Simental‐Mendía, et al.. (2016). Impact of Statin Therapy on Plasma Vitamin D Levels: A Systematic Review and Meta-Analysis. Current Pharmaceutical Design. 23(6). 861–869. 13 indexed citations
16.
Volpe, Massimo, Simon Capewell, Susanne Løgstrup, et al.. (2013). [Population-level changes to promote cardiovascular health].. 14(5). 1 indexed citations
17.
Catapano, Alberico L., Željko Reiner, Guy De Backer, et al.. (2011). ESC/EAS Guidelines for the management of dyslipidaemias. Atherosclerosis. 217(1). 3–46. 576 indexed citations breakdown →
18.
Reiner, Željko. (2009). Combined therapy in the treatment of dyslipidemia. Fundamental and Clinical Pharmacology. 24(1). 19–28. 63 indexed citations
19.
Tedeschi-Reiner, Eugenia & Željko Reiner. (2001). [Estrogens and risks for onset of atherosclerosis].. PubMed. 123(5-6). 135–41. 1 indexed citations
20.
Hebrang, Andrija, et al.. (2000). Risk factors in Croatian population. Atherosclerosis. 151(1). 141–141. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026